NEW YORK--(BUSINESS WIRE)--Neurogene Inc., a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced results of a well ...
DUBLIN--(BUSINESS WIRE)--The "Anticoagulants Market Global Forecast Report by Drug Class, Route of Administration, Distribution Channel, Application, Countries and Company Analysis 2025-2033" report ...
CHARLESTOWN, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular ...
An overview of how disease-modifying treatments for Alzheimer disease can impact medical costs and caregiver burden. Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the ...
Approved on-demand treatments for hereditary angioedema attacks need to be administered parenterally, a route of administration that is associated with delays in treatment or withholding of therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results